These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 26974879)

  • 1. Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials.
    Roberts JA; Abdul-Aziz MH; Davis JS; Dulhunty JM; Cotta MO; Myburgh J; Bellomo R; Lipman J
    Am J Respir Crit Care Med; 2016 Sep; 194(6):681-91. PubMed ID: 26974879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.
    Dulhunty JM; Roberts JA; Davis JS; Webb SA; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Starr T; Paul SK; Lipman J;
    Am J Respir Crit Care Med; 2015 Dec; 192(11):1298-305. PubMed ID: 26200166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III.
    Lipman J; Brett SJ; De Waele JJ; Cotta MO; Davis JS; Finfer S; Glass P; Knowles S; McGuinness S; Myburgh J; Paterson DL; Peake S; Rajbhandari D; Rhodes A; Roberts JA; Shirwadkar C; Starr T; Taylor C; Billot L; Dulhunty JM
    Crit Care Resusc; 2019 Mar; 21(1):63-68. PubMed ID: 30857514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.
    Abdul-Aziz MH; Sulaiman H; Mat-Nor MB; Rai V; Wong KK; Hasan MS; Abd Rahman AN; Jamal JA; Wallis SC; Lipman J; Staatz CE; Roberts JA
    Intensive Care Med; 2016 Oct; 42(10):1535-1545. PubMed ID: 26754759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial.
    Dulhunty JM; Roberts JA; Davis JS; Webb SA; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Lipman J
    Clin Infect Dis; 2013 Jan; 56(2):236-44. PubMed ID: 23074313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study.
    Dulhunty JM; Roberts JA; Davis JS; Webb SA; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Starr T; Udy AA; Paul SK; Lipman J; ;
    Crit Care Resusc; 2013 Sep; 15(3):179-85. PubMed ID: 23944203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial.
    Dulhunty JM; Brett SJ; De Waele JJ; Rajbhandari D; Billot L; Cotta MO; Davis JS; Finfer S; Hammond NE; Knowles S; Liu X; McGuinness S; Mysore J; Paterson DL; Peake S; Rhodes A; Roberts JA; Roger C; Shirwadkar C; Starr T; Taylor C; Myburgh JA; Lipman J;
    JAMA; 2024 Aug; 332(8):629-637. PubMed ID: 38864155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials.
    Vardakas KZ; Voulgaris GL; Maliaros A; Samonis G; Falagas ME
    Lancet Infect Dis; 2018 Jan; 18(1):108-120. PubMed ID: 29102324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In sepsis, continuous and intermittent infusion of β-lactam antibiotics did not differ for mortality at 90 d.
    Walker MK; Strich JR
    Ann Intern Med; 2024 Sep; 177(9):JC102. PubMed ID: 39222506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study.
    Arnold HM; Hollands JM; Skrupky LP; Smith JR; Juang PH; Hampton NB; McCormick S; Reichley RM; Hoban A; Hoffmann J; Micek ST; Kollef MH
    Ann Pharmacother; 2013 Feb; 47(2):170-80. PubMed ID: 23341160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial.
    Udy AA; Dulhunty JM; Roberts JA; Davis JS; Webb SAR; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Starr T; Paul SK; Lipman J; ;
    Int J Antimicrob Agents; 2017 May; 49(5):624-630. PubMed ID: 28286115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should β-lactam antibiotics be administered by continuous infusion in critically ill patients? A survey of Australia and New Zealand intensive care unit doctors and pharmacists.
    Cotta MO; Dulhunty JM; Roberts JA; Myburgh J; Lipman J
    Int J Antimicrob Agents; 2016 Jun; 47(6):436-8. PubMed ID: 27179814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous Infusion Versus Intermittent Bolus of Beta-Lactams in Critically Ill Patients with Respiratory Infections: A Systematic Review and Meta-analysis.
    Lee YR; Miller PD; Alzghari SK; Blanco DD; Hager JD; Kuntz KS
    Eur J Drug Metab Pharmacokinet; 2018 Apr; 43(2):155-170. PubMed ID: 29027128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loading dose and efficacy of continuous or extended infusion of beta-lactams compared with intermittent administration in patients with critical illnesses: A subgroup meta-analysis and meta-regression analysis.
    Wu CC; Su YC; Wu KS; Wu TH; Yang CS
    J Clin Pharm Ther; 2021 Apr; 46(2):424-432. PubMed ID: 33135261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.
    Abdul-Aziz MH; Hammond NE; Brett SJ; Cotta MO; De Waele JJ; Devaux A; Di Tanna GL; Dulhunty JM; Elkady H; Eriksson L; Hasan MS; Khan AB; Lipman J; Liu X; Monti G; Myburgh J; Novy E; Omar S; Rajbhandari D; Roger C; Sjövall F; Zaghi I; Zangrillo A; Delaney A; Roberts JA
    JAMA; 2024 Aug; 332(8):638-648. PubMed ID: 38864162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal.
    Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA
    Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients.
    Rafati MR; Rouini MR; Mojtahedzadeh M; Najafi A; Tavakoli H; Gholami K; Fazeli MR
    Int J Antimicrob Agents; 2006 Aug; 28(2):122-7. PubMed ID: 16815689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed regimens for the prolonged β-lactam infusion therapy.
    Hagiya H
    J Infect Chemother; 2024 Dec; 30(12):1324-1326. PubMed ID: 38977073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of prolonged infusion of beta-lactam antibiotics in patients with sepsis: personal perspectives.
    Rafailidis PI; Falagas ME
    Expert Rev Anti Infect Ther; 2020 Oct; 18(10):957-966. PubMed ID: 32564641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials.
    Tamma PD; Putcha N; Suh YD; Van Arendonk KJ; Rinke ML
    BMC Infect Dis; 2011 Jun; 11():181. PubMed ID: 21696619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.